These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1067 related items for PubMed ID: 2557422

  • 1. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats.
    Li P, Jackson EK.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):909-21. PubMed ID: 2557422
    [Abstract] [Full Text] [Related]

  • 2. Involvement of the vascular renin-angiotensin system in beta adrenergic receptor-mediated facilitation of vascular neurotransmission in spontaneously hypertensive rats.
    Kawasaki H, Cline WH, Su C.
    J Pharmacol Exp Ther; 1984 Oct; 231(1):23-32. PubMed ID: 6149303
    [Abstract] [Full Text] [Related]

  • 3. Defective modulation of noradrenergic neurotransmission by endogenous prostaglandins in aging spontaneously hypertensive rats.
    Jackson EK.
    J Pharmacol Exp Ther; 1989 Jul; 250(1):9-21. PubMed ID: 2545868
    [Abstract] [Full Text] [Related]

  • 4. Enhanced in vivo responsiveness of presynaptic angiotensin II receptor-mediated facilitation of vascular adrenergic neurotransmission in spontaneously hypertensive rats.
    Cline WH.
    J Pharmacol Exp Ther; 1985 Mar; 232(3):661-9. PubMed ID: 2983066
    [Abstract] [Full Text] [Related]

  • 5. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
    Kost CK, Herzer WA, Li P, Jackson EK.
    J Pharmacol Exp Ther; 1994 Apr; 269(1):82-8. PubMed ID: 8169855
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats.
    Vyas SJ, Jackson EK.
    J Pharmacol Exp Ther; 1995 May; 273(2):768-77. PubMed ID: 7752079
    [Abstract] [Full Text] [Related]

  • 7. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin.
    Jackson EK, Herzer WA, Mi Z, Vyas SJ, Kost CK.
    J Pharmacol Exp Ther; 1999 Oct; 291(1):115-23. PubMed ID: 10490894
    [Abstract] [Full Text] [Related]

  • 8. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
    Guidi E, Hollenberg NK.
    J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
    [Abstract] [Full Text] [Related]

  • 9. Enhanced angiotensin-mediated facilitation of adrenergic neurotransmission in spontaneously hypertensive rats.
    Kawasaki H, Cline WH, Su C.
    J Pharmacol Exp Ther; 1982 Apr; 221(1):112-6. PubMed ID: 6278133
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II-induced renal vasoconstriction in genetic hypertension.
    Jackson EK, Herzer WA, Vyas SJ, Kost CK.
    J Pharmacol Exp Ther; 1999 Oct; 291(1):329-34. PubMed ID: 10490921
    [Abstract] [Full Text] [Related]

  • 11. The inhibitory effect of angiotensin II on stimulus-induced release of cAMP is augmented in the genetically hypertensive rat kidney.
    Vyas SJ, Mi Z, Jackson EK.
    J Pharmacol Exp Ther; 1996 Oct; 279(1):114-9. PubMed ID: 8858983
    [Abstract] [Full Text] [Related]

  • 12. Effects of des-aspartate-angiotensin I on the actions of angiotensin III in the renal and mesenteric vasculature of normo- and hypertensive rats.
    Mustafa MR, Dharmani M, Kunheen NK, Sim MK.
    Regul Pept; 2004 Aug 15; 120(1-3):15-22. PubMed ID: 15177916
    [Abstract] [Full Text] [Related]

  • 13. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan 15; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA, Rattan S.
    J Pharmacol Exp Ther; 2006 Aug 15; 318(2):725-34. PubMed ID: 16648368
    [Abstract] [Full Text] [Related]

  • 15. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.
    Cruzado MC, Risler NR, Miatello RM, Yao G, Schiffrin EL, Touyz RM.
    Am J Hypertens; 2005 Jan 15; 18(1):81-7. PubMed ID: 15691621
    [Abstract] [Full Text] [Related]

  • 16. Low concentrations of angiotensin II unmask vasoconstrictory alpha 2-adrenoceptors in isolated perfused kidneys of spontaneously hypertensive rats.
    Bohmann C, Rist W, Schollmeyer P, Rump LC.
    Cardiovasc Res; 1995 Dec 15; 30(6):857-65. PubMed ID: 8746199
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats.
    Abdulla MH, Sattar MA, Abdullah NA, Hazim AI, Anand Swarup KR, Rathore HA, Khan MA, Johns EJ.
    Auton Autacoid Pharmacol; 2008 Oct 15; 28(4):95-101. PubMed ID: 18778332
    [Abstract] [Full Text] [Related]

  • 18. Different calcium storage pools in vascular smooth muscle cells from spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Neusser M, Tepel M, Golinski P, Holthues J, Spieker C, Zhu Z, Zidek W.
    J Hypertens; 1994 May 15; 12(5):533-8. PubMed ID: 7930553
    [Abstract] [Full Text] [Related]

  • 19. Evidence for a captopril-sensitive angiotensin converting enzyme in the hindquarter vasculature of SHR and WKY.
    Mueller SM, Cohen ML.
    Artery; 1985 May 15; 12(6):337-45. PubMed ID: 2996465
    [Abstract] [Full Text] [Related]

  • 20. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
    Haddad G, Garcia R.
    J Mol Cell Cardiol; 1997 Feb 15; 29(2):813-22. PubMed ID: 9140837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.